Clinical Trial Update: Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT

View source ↗

Summary

A retrospective analysis of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma treated with Z-BEAM conditioning followed by autologous ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Carmustine (carmustine)
• Etoposide (Etoposide)
• Melphalan (Melphalan)

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Refractory B-Cell Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Status: COMPLETED